CDW (CDW) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Aug, 2026Executive summary
Net sales reached $6.6 billion in Q2 2026, up 10% year-over-year, driven by strong demand in infrastructure modernization, cloud, AI, and hardware/software solutions.
Gross profit increased 6.3% to $1.3 billion, with gross margin at 20.1%, down 70 basis points due to product mix shift toward lower-margin hardware.
Operating income rose 2% to $429 million; non-GAAP operating income was $556 million, up 7%.
Net income was $274 million, up 1.2% year-over-year; non-GAAP net income was $370 million, with non-GAAP EPS up 11.9% to $2.91.
All-time quarterly records were set for net sales, gross profit, and non-GAAP EPS, reflecting strong execution amid dynamic technology trends.
Financial highlights
Commercial net sales grew 9.2% to $3.97 billion; Corporate up 10.7%, Healthcare up 9.1%, Financial Services up 1.8%.
Government net sales increased 13.6% to $848 million; Education up 0.7% to $933 million; UK/Canada up 22.9% to $826 million.
Gross margin was 20.1%, down 70 basis points year-over-year; operating margin was 6.5%, down from 7.0%.
Non-GAAP operating income margin was 8.5%; non-GAAP net income margin was 4.2%.
Adjusted free cash flow year-to-date was $278 million, or 42% of non-GAAP net income, below the 80%-90% target due to higher inventory investments.
Outlook and guidance
Full-year outlook raised: U.S. IT addressable market expected to grow mid-single digits in 2026, with 200-300 basis points of outperformance.
Gross profit for 2026 expected to grow mid-single digits; non-GAAP EPS growth at the high end of high single digits.
Second half of 2026 expected to show more typical seasonality, with gross margins modestly below 2025 but above pre-pandemic levels.
Currency expected to be a slight benefit to reported growth rates.
Management remains focused on balancing growth investments with operational efficiency and disciplined capital allocation.
Latest events from CDW
- Q3 2024 sales fell 2% year-over-year, but margins and cash flow remained strong.CDW
Q3 20249 Jul 2026 - Q4 sales up 3.3%–5% with healthcare strength; 2025 targets low single-digit profit growth.CDW
Q4 20248 Jul 2026 - Hardware and cloud refresh cycles, AI, and services drive optimism for 2025 growth.CDW
UBS Global Technology and AI Conference8 Jul 2026 - Directors re-elected, margin pressures discussed, and independent chair proposal rejected.CDW
AGM 202621 May 2026 - AI-driven services, operational efficiency, and recurring revenue models fuel growth and value.CDW
J.P. Morgan 54th Annual Global Technology, Media and Communications Conference19 May 2026 - Net sales rose 9.2% to $5.68B, with broad segment growth and continued AI investment.CDW
Q1 20266 May 2026 - Board recommends approval of all proposals except the independent board chair requirement.CDW
Proxy filing10 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and governance changes.CDW
Proxy filing10 Apr 2026 - Proxy covers director elections, pay, auditor, and shareholder rights, with board independence emphasized.CDW
Proxy filing27 Mar 2026